ENACT - REACT COVID (risk assessment)

Start Date

March 2020

Duration

6 months

placeholder.jpg
placeholder_edited.jpg

Title: Registry of COVID-19 Patients at AOUI Verona (ENACT – REACT COVID)


Design: Observational cohort study


Registration Number: Institutional Review Board: 2577CESC; ClinicalTrials.gov: NCT04497194


Primary Objective: to explore epidemiological and clinical predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona


Secondary Objective(s):

-          To identify anamnestic and laboratory predictors of early clinical progression in COVID-19 patients;

-          To provide a prediction model for early identification of COVID-19 patients at risk of developing a potentially life-threatening disease


Interested in collaboration? Contact: Elisa Gentilotti, elisa.gentilotti@univr.it


Publications: N/A

Partners

University of Verona

ID-CARE

  • Alessia Savoldi

  • Elda Righi

  • Elena Carrara

  • Elisa Gentilotti

  • Elisa Razzaboni

  • Evelina Tacconelli

  • Fabio Soldani

  • Monica Compri

  • Pasquale De Nardo